Red-Hot Drug Stock Jumps Again

The Dow managed to bounce back after slipping below the breakeven this morning

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

MIDDAY MARKET CHECK     1/15/2020
This Pot Stock Could Be The Next Procter & Gamble A tiny cannabis company is about to disrupt Latin America's $31.98 billion cosmetics industry with a revolutionary new line of CBD beauty products. Then it's on to conquer CBD health care...skin care...and even the pet care markets. So far this company's flying under Wall Street's nose... But not for long.
Dow Hits New High on Blue-Chip Earnings By Lillian Currens Share On The Dow Jones Industrial Average (DJI) initially slipped out of the gate on concerning comments from Treasury Secretary Steven Mnuchin. The blue-chip index has since bounced back to hit a record high, with the trade deal signing currently underway. Comments from National Economic Council Director Larry Kudlow that U.S. President Donald Trump could unveil another round of potential tax cuts later this year also helped boost stocks, with the S&P 500 Index (SPX) and Nasdaq Composite (IXIC) nabbing new highs, as well. Elsewhere, focus remains on earnings, with Goldman Sachs (GS) and UnitedHealth (UNH) getting a boost on well-received reports. Meanwhile, Target (TGT) stock is sinking on disappointing holiday sales data.  Continue reading for more on today's market, including: Volatile Beyond Meat stock is making another big move.  The red-hot drug stock that's jumping again.  Plus, calls pop on surging Shake Shack; CETX stock doubles; NKTR stock drops on opioid ruling.  >> Continue reading...
LATEST HEADLINES
>> Shake Shack Calls Hot as Stock Breaks Out A short squeeze could keep the upside going >> JPM Stock Nears Record Highs on Price-Target Hikes Analysts are surrounding JPM with price-target hikes today >> Target Puts Popular After Dismal Holiday Sales Puts have been popular for some time now >> FDA Nod Sends CLVS Stock Skyrocketing The FDA just granted the stock's advanced prostate cancer treatment priority review status >> Stock Futures Drift Lower Ahead of "Phase One" Signing Goldman Sachs and Bank of America both reported earnings beats Sponsored A rare "private placement" opportunity in cannabis Right now you've got a short window to get in on a tiny new company set upperfectly to dominate the cannabis market. From CBD-infused cosmetic, skin, and pet care products...to medical marijuana...to THC-based consumables...and everything in between...This company's positioned to profit from virtually every kind of pot-based product you can think of. Yet Wall Street's hardly aware of it. Institutional buyers sure are, though, but they can't buy it...yet. It's the most exciting - and overlooked - opportunity in the new cannabis sector today.
To ensure delivery of Schaeffer's Midday Market Check, add us to your contacts! For more information, please visit this link for further instructions. This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Midday Market Check or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Midday Market Check? You can unsubscribe here. For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions. Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:
		SCHAEFFER'S MIDDAY MARKET CHECK enews@schaeffer.com 5151 Pfeiffer Rd. Suite 250 Cincinnati, OH, 45242 USA 800-448-2080 www.schaeffersresearch.com